APN News

  • Tuesday, October, 2021| Today's Market | Current Time: 03:48:52
  • Octapharma:EMA Recommends to Lift the Suspension of the Marketing Authorization of octagam

    Switzerland: The Committee for Medicinal Products for Human Use (CHMP) of the The European Medicines Agency (EMA) has recommended today to lift the EU-wide suspension of the marketing authorizations of both octagam® and octagam®10% which has been in place since September 2010, subject to certain conditions. The background to the suspension in September 2010 was […]

    Teen Birth Rate Drops In USA, But Still Much Higher Than Other Industrialized Nations

    Over the last two decades, there has been a 40% drop in the teenage birth rate, according to a new report by the CDC (Centers for Disease Control and Prevention). However, with 400,000 teenage girls having babies each year, about 1,110 per day, the USA has a very long way to go to catch up […]

    Patanjali Ayurved Beverages in Tetra Pak packages

    Haridwar: Patanjali Ayurved Limited, founded by Swami Ramdev , on Monday  announced the launch of its new range of  health beverages.  The health range currently includes a 100% apple juice and an amla beverage but in the offing are a slew of products catering to the fast-growing awareness about health and wellness amongst urban and […]

    TN Health Summit 2011

    Chennai: Healthcare has emerged to be one of the most progressive service sectors in India is believed to be the next big thing after IT! The Indian healthcare sector is expected to become a US$ 280 billion by 2020 with spending on health estimated to grow 14 per cent annually. India has increasingly become the […]

    NHS SBS, a Joint Venture between Steria and Department of Health UK, Wins (€15m) £13.5m Contract Extension with ten NHS Trusts in Hampshire and the Isle of Wight

    Uttar Pradesh: NHS Shared Business Services has today announced it has renewed its long-term strategic contract with ten NHS organisations across Hampshire and the Isle of Wight, worth €15m (£13.5m) over an additional four years. Starting 1st April 2011, the contract includes the provision of Finance & Accounting and Payroll Services and follows the merger […]

    BIOTRONIK Cardiac Device Donation Helps 75 Impoverished Heart Patients in Trinidad and Tobago

    Germany: BIOTRONIK SE Co. & KG, a leading manufacturer of implantable cardiac devices, has provided a donation of implantable cardiac defibrillators (ICD) and pacemaker device implants to more than 75 low-income and impoverished patients in the Republic of Trinidad & Tobago as part of its collaboration with Heartbeat International Foundation Inc. (HBI). Globally, one to […]

    WHO highlights action on antibiotic use on the occasion of ‘Health Day’

    The World Health Organisation has warned that drug resistance fueled partly by a misuse of antibiotics is killing hundreds of thousands of people a year and that urgent action was needed on the issue. “We’re really seeing an accelerated evolution in the spread of this problem and the bottomline is that the problem is outpacing […]

    CSR and Growth must go Hand in Hand for Inclusive Growth: K D Singh, Chairman, Alchemist Group

    New Delhi : Mr K D Singh, Rajya Sabha MP, and the man behind the 10000 crore Alchemist Group says that now the time has come for corporates to not only focus on just profits but do so with a much more bigger focus on corporate social responsibility. Commenting on the renewed debate on Corporate […]

    BIOTRONIK Announces Positive 6-month Results for Pantera Lux Paclitaxel Releasing Balloon

    United States: Six-month results from the PEPPER (Paclitaxel REleasing Balloon in Patients PresEnting with In-Stent Restenosis) study demonstrating a very low number of revascularizations and no cardiac deaths were presented on Sunday at the American College of Cardiology (ACC) conference by Professor Christoph Hehrlein, MD, University Medical Center, Freiburg, Germany and clinical coordinating investigator of […]

    Breakthrough therapy dabigatran provides consistent benefit across all atrial fibrillation types and stroke risk groups

    Germany: New data from two RE-LY® sub-group analyses has presented at the 60th Annual Scientific Session of the American College of Cardiology (ACC) demonstrated that dabigatran etexilate 150mg bid is consistently superior to warfarin in stroke prevention in atrial fibrillation (AF), irrespective of a patient’s risk of stroke or type of AF.1,2 RE-LY®, the largest […]